Preface
Preface
Annals of Translational Medicine
2016;
4
(17)
:323
(September 2016)
Review Article
Current epidemiology of sepsis in mainland China
Annals of Translational Medicine
2016;
4
(17)
:324
(September 2016)
Epidemiologic trends of sepsis in western countries
Annals of Translational Medicine
2016;
4
(17)
:325
(September 2016)
Resistance mechanisms
Annals of Translational Medicine
2016;
4
(17)
:326
(September 2016)
The immunocompromised oncohematological critically ill patient: considerations in severe infections
Annals of Translational Medicine
2016;
4
(17)
:327
(September 2016)
The role of genetics and antibodies in sepsis
Annals of Translational Medicine
2016;
4
(17)
:328
(September 2016)
New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure
Annals of Translational Medicine
2016;
4
(17)
:329
(September 2016)
Current understanding in source control management in septic shock patients: a review
Annals of Translational Medicine
2016;
4
(17)
:330
(September 2016)
Right first time!
Annals of Translational Medicine
2016;
4
(17)
:331
(September 2016)
Implementing sepsis bundles
Annals of Translational Medicine
2016;
4
(17)
:332
(September 2016)
Vasoactive agents for the treatment of sepsis
Annals of Translational Medicine
2016;
4
(17)
:333
(September 2016)
Disclosure:
The focused issue“Management of Infections in Septic Shock”was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Jordi Rello and Hakan Erdem served as the unpaid Guest Editors for the focused issue.